Share This

PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
US-Based Neurobiotic Leader Bened Life enters Japan market with Neuralli™ MP
2024-05-29T    Banking/Financial Service   Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
TREEFROG THERAPEUTICS PICKS-UP BEST POSTER AWARD AT THE INTERNATIONAL SOCIETY FOR CELL & GENE THERAPY (ISCT) ANNUAL MEETING FOR THEIR CELL THERAPY PROGRAM IN PARKINSON'S DISEASE
2024-05-29T    Banking/Financial Service   Biotechnology   Computer/Electronics   Health Care/Hospital 
GC Cell participates 2024 BIO International Convention, Unveiling its future Blueprint 2.0, as the First Korean Business Forum Sponsor
2024-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals   Trade show news 
Rege Nephro CO., Ltd. Announces Patient Enrollment for Phase II Clinical Trial of Tamibarotene for ADPKD
2024-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Metabolon Now Includes Spectral Data Files for All Global Discovery Panel Projects
2024-05-28T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for Eye and Ear Diseases
2024-05-28T    Banking/Financial Service   Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear Therapies
2024-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Stavian Chemical Ranks 17th in ICIS Top 100, Signaling Strong Growth Amid Global Market Challenges
2024-05-28T    Banking/Financial Service   Biotechnology   Chemical   Environmental Products & Services 
Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA to the NMPA
2024-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Telix Submits NDA for New Prostate Cancer Imaging Agent
2024-05-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.